Association with lipids or detergents is essential for preservation of the active structure of lipoprotein-associated phospholipase A2

被引:2
作者
Zhuo, Shaoqiu [1 ,2 ]
Yuan, Chong [1 ]
机构
[1] Diazyme Labs Inc, 12889 Gregg Ct, Poway, CA 92064 USA
[2] Bayer HealthCare, 800 Dwight Way, Berkeley, CA 94710 USA
关键词
Lipoprotein; Phospholipase A(2); Aggregation; Protein stability; Lipid; ACTIVATING-FACTOR-ACETYLHYDROLASE; DARAPLADIB; BINDING; EVENTS;
D O I
10.1016/j.chemphyslip.2019.104814
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant lipoprotein-associated phospholipase A(2) (rLp-PLA(2)) expressed in HEK293 cells has a propensity to form oligomers in the absence of detergents. Dilution of rLp-PLA(2) in the absence of detergents results in irreversible inactivation of the enzyme. The monomeric rLp-PLA(2) may expose its hydrophobic interfacial binding region or substrate binding compartment to water and that may cause structural collapsing of the enzyme. Formation of self-aggregate, complex with binding partners or association with detergent micelles is to block the access of aqueous solvent to the hydrophobic substrate binding site and therefore prevents the structural collapsing. Dilution inactivation of the enzyme can be prevented in the presence of LDL or HDL suggesting that LpPLA(2) association with lipoprotein particles (LDL and HDL) is necessary for Lp-PLA(2) to maintain its enzymatic activity in human plasma. Formation of higher affinity complex gave better protection of rLp-PLA(2) structure and activity. The method can be harnessed to detect the interaction between rLp-PLA(2) and components of lipoprotein particles. Apo(a), ApoB 100 and ApoA1 were found to protect the enzyme from inactivation at roughly the similar level ((similar to)80 +/- 5%) comparing to human serum albumin control ((similar to)40%). One mg/ml pig brain phospholipid showed 100% protection under the same conditions.
引用
收藏
页数:8
相关论文
共 22 条
  • [1] [Anonymous], 2001, GUIDE PROPERTIES USE
  • [2] Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma
    Asano, K
    Okamoto, S
    Fukunaga, K
    Shiomi, T
    Mori, T
    Iwata, M
    Ikeda, Y
    Yamaguchi, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 511 - 514
  • [3] Phospholipase A2 Biochemistry
    Burke, John E.
    Dennis, Edward A.
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) : 49 - 59
  • [4] Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein
    Gardner, Alison A.
    Reichert, Ethan C.
    Topham, Matthew K.
    Stafforini, Diana M.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (25) : 17099 - 17106
  • [5] Aggregation number for sodium deoxycholate from steady-state and time-resolved fluorescence
    Jover, A
    Meijide, F
    Nunez, ER
    Tato, JV
    Mosquera, M
    [J]. LANGMUIR, 1997, 13 (02) : 161 - 164
  • [6] Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia
    Karabina, SAP
    Elisaf, M
    Bairaktari, E
    Tzallas, C
    Siamopoulos, KC
    Tselepis, AD
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (07) : 595 - 602
  • [7] Stimulation of specific binding of [3H]-progesterone to bovine luteal cell-surface membranes:: specificity of digitonin
    Menzies, GS
    Howland, K
    Rae, MT
    Bramley, TA
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 153 (1-2) : 57 - 69
  • [8] Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial
    O'Donoghue, Michelle L.
    Braunwald, Eugene
    White, Harvey D.
    Steen, Dylan P.
    Lukas, Mary Ann
    Tarka, Elizabeth
    Steg, P. Gabriel
    Hochman, Judith S.
    Bode, Christoph
    Maggioni, Aldo P.
    Im, KyungAh
    Shannon, Jennifer B.
    Davies, Richard Y.
    Murphy, Sabina A.
    Crugnale, Sharon E.
    Wiviott, Stephen D.
    Bonaca, Marc P.
    Watson, David F.
    Weaver, W. Douglas
    Serruys, Patrick W.
    Cannon, Christopher P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (10): : 1006 - 1015
  • [9] Crystal Structure of Human Plasma Platelet-activating Factor Acetylhydrolase STRUCTURAL IMPLICATION TO LIPOPROTEIN BINDING AND CATALYSIS
    Samanta, Uttamkumar
    Bahnson, Brian J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (46) : 31617 - 31624
  • [10] Crystallization and Preliminary X-Ray Crystallographic Analysis of Human Plasma Platelet Activating Factor Acetylhydrolase
    Samanta, Uttamkumar
    Wilder, Cheryl
    Bahnson, Brian J.
    [J]. PROTEIN AND PEPTIDE LETTERS, 2009, 16 (01) : 97 - 100